Page last updated: 2024-08-24

atorvastatin and cyclosporine

atorvastatin has been researched along with cyclosporine in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.63)	18.2507
2000's	18 (47.37)	29.6817
2010's	14 (36.84)	24.3611
2020's	5 (13.16)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Bracha, AL; Huang, S; Ingber, DE; Ramanathan, A; Schreiber, SL	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Barton, P; Ismair, M; Jupp, R; Riley, RJ; Soars, MG	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Balog, DL; Cheigh, JS; Maltz, HC	1
Stewart, BH; Whitfield, LR; Wu, X	1
Böhmig, G; Demetriou, D; Hörl, WH; Schmaldienst, S; Shabpar, A; Watschinger, B	1
Burkhardt, K; Hauser, IA; Koch, C; Mayer-Kadner, I; Renders, L; Schärffe, S; Schmieder, RE; Veelken, R	1
Asberg, A; Bergan, S; Fjeldså, E; Hartmann, A; Holdaas, H	1
Allen, J; Butler, M; Kubler, PA; Lynch, SV; Pillans, PI; Taylor, PJ	1
Chan, KH; Chau, E; Lai, KC; Wai-Hung Shek, T; Wong, WM	1
Asberg, A; Christensen, H; Hartmann, A; Hermann, M; Holdaas, H; Reubsaet, JL	2
Das, V; Shrivastava, R; Singh, S	1
Hess, L; Krähenbühl, S; Krähenbühl-Melcher, A; Rätz Bravo, AE; Schlienger, RG; Tchambaz, L	1
Burton, I; Koshman, SL; Lalonde, LD; Pearson, GJ; Tymchak, WJ	1
Asberg, A; Hermann, M; Holdaas, H; Lemahieu, WP; Maes, BD; Vanrenterghem, Y; Verbeke, K	1
Barsotti, G; Carpi, A; Consani, C; Manca-Rizza, G; Mantuano, E; Marchetti, V; Panichi, V; Paoletti, S; Sbragia, G; Taccola, D	1
Gu, M; Liu, M; Wu, Y; Yin, C; Zhang, W; Zhu, P	1
Chen, XJ; Dong, J; Sun, YB; Wang, GJ; Wang, L; Yu, X	1
de Barros e Silva, MJ; de Paiva, TF; Fanelli, MF; Gimenes, DL; Rinck, JA	1
Aliabadi, AZ; Dunkler, D; Grimm, M; Grömmer, M; Mahr, S; Wolner, E; Zimpfer, D; Zuckermann, AO	1
Hoskova, L; Kautzner, J; Kubanek, M; Malek, I; Podzimkova, M; Skalicka, B; Vymetalova, Y	1
Amundsen, R; Asberg, A; Christensen, H; Zabihyan, B	1
Haron, MM; Houssen, ME; Ibrahim, TM; Metwally, SS	1
Enache, I; Garrouste, C; Heng, AE; Kaysi, S; Philipponnet, C; Tiple, A	1
Davidson, SM; Elliot, PM; Harding, SE; Hausenloy, DJ; McGregor, C; Rees, PS; Yellon, DM	1
Ben-Eltriki, M; Brocks, DR; Chaudhary, HR; El-Kadi, AO; Elsherbiny, ME	1
Dong, B; He, J; Huang, X; Mo, L; Yue, Q	1
Bašić-Jukić, N; Ivandić, E	1
Burger, D; Maliepaard, M; Neef, C; Teerenstra, S; Yu, Y	1
Carter, SJ; Chappell, MJ; Ferecskó, AS; King, L; Ménochet, K; Parton, T	1
Asal, NJ; Migliozzi, DR	1
Li, P; Liu, L; Liu, X; Wang, Z; Yang, Y; Zhang, Z	1
Harabayashi, R; Nagayama, K; Nakamura, Y; Sugimoto, T; Takahashi, K; Takahashi, M; Uchida, J	1

Reviews

3 review(s) available for atorvastatin and cyclosporine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022
Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions. The Annals of pharmacotherapy, 2020, Volume: 54, Issue:2 Topics: Adult; Atorvastatin; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Liver-Specific Organic Anion Transporter 1; Organ Transplantation; Simvastatin; Tacrolimus	2020

Trials

7 trial(s) available for atorvastatin and cyclosporine

Article	Year
Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation. Wiener klinische Wochenschrift, 2000, Apr-21, Volume: 112, Issue:8 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Pyrroles; Treatment Outcome; Triglycerides	2000
Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:1 Topics: Adult; Aged; Atorvastatin; Cardiovascular Diseases; Cyclosporine; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyridines; Pyrroles; Safety	2001
Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2001, Volume: 1, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Area Under Curve; Atorvastatin; Basiliximab; Cyclosporine; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisolone; Pyrroles; Recombinant Fusion Proteins	2001
Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:2 Topics: Adult; Aged; Area Under Curve; Atorvastatin; Cholesterol; Cyclosporine; Drug Interactions; Female; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Pyrroles; Treatment Outcome	2004
Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients. Clinical pharmacology and therapeutics, 2004, Volume: 76, Issue:4 Topics: Adult; Anticholesteremic Agents; Area Under Curve; Atorvastatin; Chromatography, High Pressure Liquid; Cyclosporine; Drug Interactions; Female; Heptanoic Acids; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mass Spectrometry; Middle Aged; Pyrroles	2004
Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients. European journal of clinical pharmacology, 2005, Volume: 61, Issue:1 Topics: Anticholesteremic Agents; Area Under Curve; Atorvastatin; Cyclosporine; Drug Interactions; Half-Life; Heptanoic Acids; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Pyrroles	2005
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:9 Topics: Area Under Curve; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Indoles; Lactones; Liver; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pravastatin; Pyrroles; Simvastatin; Tacrolimus; Time Factors	2005

Other Studies

28 other study(ies) available for atorvastatin and cyclosporine

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Carbon metabolism-mediated myogenic differentiation. Nature chemical biology, 2010, Volume: 6, Issue:3 Topics:	2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:8 Topics: Cell Line; Drug Discovery; Humans; Liver-Specific Organic Anion Transporter 1; Organic Anion Transporters	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:11 Topics: Anticholesteremic Agents; Atorvastatin; Cadaver; Clinical Enzyme Tests; Cyclosporine; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Pyrroles; Rhabdomyolysis	1999
Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharmaceutical research, 2000, Volume: 17, Issue:2 Topics: Acetic Acid; Anion Transport Proteins; Antineoplastic Agents, Phytogenic; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoic Acid; Biological Transport; Caco-2 Cells; Calcium Channel Blockers; Carbon Radioisotopes; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Carboxylic Acids; Carrier Proteins; Cell Polarity; Cyclosporine; Drug Interactions; Heptanoic Acids; Humans; Hydrogen-Ion Concentration; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Indicators and Reagents; Ionophores; Niacin; Protons; Pyrroles; Verapamil; Vinblastine	2000
Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy. Journal of gastroenterology and hepatology, 2004, Volume: 19, Issue:8 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Colon; Colonoscopy; Cyclosporine; Cytomegalovirus Infections; Drug Interactions; Heart Transplantation; Heptanoic Acids; Humans; Immunosuppressive Agents; Male; Postoperative Complications; Pyrroles; Rhabdomyolysis; Treatment Outcome	2004
Formulary conversion programs: the need for patient-specific risk assessment. MedGenMed : Medscape general medicine, 2004, Sep-14, Volume: 6, Issue:3 Topics: Aged; Atorvastatin; Cyclosporine; Drug Interactions; Female; Formularies as Topic; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Postoperative Care; Pyrroles; Rhabdomyolysis; Risk Assessment; Simvastatin	2004
Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy. Drug safety, 2005, Volume: 28, Issue:3 Topics: Aged; Ambulatory Care; Aryl Hydrocarbon Hydroxylases; Atorvastatin; Comorbidity; Cross-Sectional Studies; Cyclosporine; Cytochrome P-450 CYP3A; Digoxin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Indoles; Male; Niacin; Oxidoreductases, N-Demethylating; Physicians; Pravastatin; Prevalence; Product Surveillance, Postmarketing; Pyrroles; Simvastatin; Time Factors	2005
Supratherapeutic response to ezetimibe administered with cyclosporine. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:9 Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Cyclosporine; Drug Interactions; Ezetimibe; Heart Transplantation; Heptanoic Acids; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Pyrroles	2005
Safety and effects on the lipid and C-reactive protein plasma concentration of the association of ezetimibe plus atorvastatin in renal transplant patients treated by cyclosporine-A: a pilot study. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2006, Volume: 60, Issue:5 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Azetidines; C-Reactive Protein; Cyclosporine; Drug Combinations; Ezetimibe; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Lipids; Male; Middle Aged; Pilot Projects; Pyrroles; Triglycerides	2006
Protective effects of atorvastatin on chronic allograft nephropathy in rats. The Journal of surgical research, 2007, Volume: 143, Issue:2 Topics: Animals; Anticholesteremic Agents; Atorvastatin; Chemokines; Chronic Disease; Cyclosporine; Cytokines; Drug Therapy, Combination; Extracellular Matrix Proteins; Fibrosis; Gene Expression; Graft Rejection; Heptanoic Acids; Immunosuppressive Agents; Kidney Transplantation; Male; Monocytes; Proteinuria; Pyrroles; Rats; Rats, Inbred F344; Rats, Inbred Lew; T-Lymphocytes; Transplantation, Homologous	2007
Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats. Acta pharmacologica Sinica, 2008, Volume: 29, Issue:10 Topics: Animals; Antifungal Agents; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Calibration; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Injections, Intravenous; Intubation, Gastrointestinal; Itraconazole; Male; Pyrroles; Rats; Rats, Sprague-Dawley	2008
Tuberculosis in a patient on temozolomide: a case report. Journal of neuro-oncology, 2009, Volume: 92, Issue:1 Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antibiotics, Antitubercular; Anticholesteremic Agents; Anticonvulsants; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Combined Modality Therapy; Cyclosporine; Dacarbazine; Dexamethasone; Female; Fluoxetine; Glioblastoma; Heptanoic Acids; Humans; Immunosuppressive Agents; Isoniazid; Middle Aged; Omeprazole; Phenobarbital; Prednisone; Pyrazinamide; Pyrroles; Radiotherapy; Red-Cell Aplasia, Pure; Rifampin; Temozolomide; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary	2009
Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation. Transplantation, 2008, Dec-27, Volume: 86, Issue:12 Topics: Adrenal Cortex Hormones; Aged; Atorvastatin; Cholesterol; Cyclosporine; Dyslipidemias; Female; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Postoperative Complications; Pravastatin; Pyrroles; Safety; Sirolimus; Treatment Outcome; Triglycerides	2008
Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2009, Volume: 28, Issue:6 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Heart Transplantation; Heptanoic Acids; Humans; Immunosuppressive Agents; Indoles; Male; Middle Aged; Prospective Studies; Pyrroles; Tacrolimus; Treatment Outcome; Triglycerides	2009
Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:9 Topics: Atorvastatin; Cell Line; Cyclosporine; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Organic Anion Transporters; Pyrroles; Tacrolimus	2010
Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis. Journal of physiology and biochemistry, 2011, Volume: 67, Issue:1 Topics: Animals; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Heptanoic Acids; Immunologic Factors; Inflammation; Interferon-gamma; Interleukin-6; Male; Plasma; Pyrroles; Rabbits; Tacrolimus; Triglycerides	2011
Severe colchicine intoxication in a renal transplant recipient on cyclosporine. Transplantation proceedings, 2012, Volume: 44, Issue:9 Topics: Acute Kidney Injury; Atorvastatin; Colchicine; Cyclosporine; Drug Interactions; Gout; Gout Suppressants; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrroles; Quadriplegia; Rhabdomyolysis; Treatment Outcome	2012
The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:3 Topics: Atorvastatin; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cells, Cultured; Cyclosporine; Heptanoic Acids; Humans; Ion Channel Gating; Membrane Potential, Mitochondrial; Microscopy, Confocal; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocytes, Cardiac; Pyrroles; Time Factors	2013
Effects of serum lipoproteins on cyclosporine A cellular uptake and renal toxicity in vitro. Canadian journal of physiology and pharmacology, 2014, Volume: 92, Issue:2 Topics: Animals; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cyclosporine; Hepatocytes; Heptanoic Acids; Hypolipidemic Agents; Immunosuppressive Agents; Kidney; Lipoproteins; Pyrroles; Rats; Rats, Sprague-Dawley	2014
Increased dosage of cyclosporine induces myopathy with increased seru creatine kinase in an elderly patient on chronic statin therapy. Journal of clinical pharmacy and therapeutics, 2015, Volume: 40, Issue:2 Topics: Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Atorvastatin; China; Cyclosporine; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Repression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Male; Muscular Diseases; Myoglobin	2015
[Liver damage caused by atorvastatin and cyclosporine in patients with renal transplant]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2014, Volume: 68, Issue:2 Topics: Atorvastatin; Chemical and Drug Induced Liver Injury; Cyclosporine; Graft Rejection; Graft Survival; Heptanoic Acids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Liver; Male; Middle Aged; Pyrroles	2014
Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines. European journal of clinical pharmacology, 2015, Volume: 71, Issue:8 Topics: Anilides; Area Under Curve; Atorvastatin; Benzodiazepines; Chemistry, Pharmaceutical; Cyclosporine; Drugs, Generic; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nitriles; Olanzapine; Perindopril; Piperidines; Tacrolimus; Therapeutic Equivalency; Tosyl Compounds; Tryptamines; Venlafaxine Hydrochloride	2015
A mechanistic modelling approach for the determination of the mechanisms of inhibition by cyclosporine on the uptake and metabolism of atorvastatin in rat hepatocytes using a high throughput uptake method. Xenobiotica; the fate of foreign compounds in biological systems, 2020, Volume: 50, Issue:4 Topics: Animals; Atorvastatin; Biological Transport; Cyclosporine; Hepatocytes; Liver; Models, Chemical; Rats	2020
Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes. International journal of molecular sciences, 2020, Sep-24, Volume: 21, Issue:19 Topics: Atorvastatin; Biological Transport; Computer Simulation; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Humans; Intestines; Liver; Models, Biological	2020
Safety Profile of the Concomitant Use of Atorvastatin and Cyclosporine in Renal Transplant Recipients. Die Pharmazie, 2023, 05-01, Volume: 78, Issue:5 Topics: Atorvastatin; Cyclosporine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Retrospective Studies; Tacrolimus	2023